January 4, 2024 10:54 AM EST
Financing
Startups
R&D

Claris rais­es $57M in Se­ries A as it awaits key tri­al read­out on eye drug

Lei Lei Wu

News Reporter

Claris an­nounced a $57 mil­lion Se­ries A on Thurs­day morn­ing as it launched from stealth. The Jer­sey City biotech is work­ing …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

Jazz wins ap­proval for bis­pe­cif­ic in bil­iary tract can­cer

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

FDA ad­comm rais­es risk ques­tions on As­traZeneca’s An­dexxa

At Jef­feries, all that man­u­fac­tur­ers want to talk about is GLP-1s

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times